Miguel Ángel Gastelurrutia Garralda

Resultados negativos asociados a la medicación

En la actualidad los conceptos de Problemas Relacionados con Medicamentos (PRM) y Resultados Negativos Asociados a la Medicacion (RNM) ya consensuados, se encuentran bien integrados en la practica farmaceutica, aunque se han detectado ciertas discrepancias en la interpretacion de estos conceptos que precisan aclaracion. En la presente nota clinica se procede, de acuerdo a la evidencia aportada, a clarificar estos conceptos fundamentalmente en los que se refieren a la categoria de necesidad.

Common health problems management uncertainties in heart failure: a qualitative study.

BACKGROUND Medicine review with follow up quantitative studies conducted on heart failure (HF) outpatients detected health problems that were frequently treated insufficiently: hyperuricemia, gastric injury prevention, anemia, and diabetes mellitus. OBJECTIVE The aim of this qualitative study was to explore experiences in the pharmacological management of these health problems, and to contribute with strategies to overcome the identified obstacles. METHODS The internal medicine specialists and cardiologists of a tertiary hospital HF clinic underwent in-depth semi-structured interviews and a constant comparative approach was used. RESULTS Interviewees highlighted there is a lack of guidelines concerning the treatment of asymptomatic hyperuricemia in HF, thus in routine practice it is often not treated. Interviewees said that preventive strategies to avoid gastric injury in at-risk patients taking prophylactic low-dose aspirin are needed, but the most appropriate strategy is not well defined. Interviewees thought that structural support is needed for the management of HF patients with anemia, and proper clinic pathways should be created to identify which service patients should be referred to. The same lack of communication with other services appeared with diabetes mellitus. CONCLUSION HF specialists demand a closer interaction with other specialists for a comprehensive approach to these polymedicated patients with multiple co-morbidities. And suggest that specific recommendations in HF guidelines to manage these co-morbidities specifically in HF would be helpful to shed light upon the existing confusing evidence.